A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Clinical trial NCT05628857 · COMPLETED

Trial details

NCT number: NCT05628857
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Digestive Cancer

Start date: 2022-11-11
Primary completion: 2025-12-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.